# data[].attributes.body
Public Health Threat: Non-compliance can lead to the release of infectious agents, causing disease outbreaks, epidemics, or even pandemics.

Worker Safety: Employees handling biohazards may face exposure, leading to illness, injury, or death.

# data[].attributes.body
Fines:

Regulatory agencies, such as OSHA, EPA, and CDC, impose heavy fines for non-compliance. For example:

OSHA fines for violating safety standards can exceed $15,625 per violation (as of 2024).

EPA penalties for improper disposal of infectious waste can range from $70,000 to $500,000 per violation, depending on severity and negligence.

# data[].attributes.body
Willful negligence or intentional violations (e.g., unauthorized release of select agents) can lead to criminal prosecution.

Penalties include fines up to $500,000, imprisonment (up to 10 years), or both under federal laws like the Bioterrorism Act and the Select Agent Regulations.

License Revocation:

Laboratories may lose their license to operate, and researchers may face revocation of credentials or bans from future work.

Lawsuits:

Institutions may face lawsuits from affected individuals or communities for damages due to exposure or harm caused by non-compliance

# data[].attributes.body
Loss of Funding:

Federal or private research grants may be suspended or terminated. Agencies like NIH or CDC may cut funding for institutions found non-compliant.

Reputation Damage:

Non-compliance erodes public trust, resulting in reputational damage that can affect future partnerships, collaborations, and recruitment.

Operational Shutdowns:

Government agencies may order the temporary or permanent shutdown of facilities for egregious violations.

# data[].attributes.body
a. Biosafety Levels (BSL)

Description: Laboratories are classified into Biosafety Levels 1-4 (BSL-1 to BSL-4) based on the risk posed by the biological agents being handled.

Key Source: Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition (CDC and NIH).

Scope: Outlines containment protocols, equipment, and facilities required for handling infectious agents based on their hazard level.

b. Occupational Safety Standards

Source: Occupational Safety and Health Administration (OSHA).

Key Standards:

Bloodborne Pathogens Standard (29 CFR 1910.1030): Protects workers exposed to bloodborne pathogens (e.g., HIV, Hepatitis B).

Hazard Communication Standard (29 CFR 1910.1200): Ensures workers are informed about hazardous chemicals used with biohazards.

c. Infectious Waste Management

Source: Environmental Protection Agency (EPA).

Guidelines:

Management of Medical and Infectious Waste under the Resource Conservation and Recovery Act (RCRA).

Ensures proper treatment, storage, and disposal of biohazardous waste, including autoclaving, incineration, and chemical disinfection.

d. Select Agent Program

Source: CDC and USDA.

Purpose: Regulates possession, use, and transfer of select agents and toxins (biological agents with potential for bioterrorism) under the Federal Select Agent Program.

e. World Health Organization (WHO) Guidelines

Resource: WHO Laboratory Biosafety Manual (4th Edition).

Scope: International standards for laboratory biosafety, risk assessment, and handling of infectious diseases.

# data[].attributes.headline
Case Study: Biohazard Release at Tulane National Primate Research Center

# data[].attributes.subject
Case Study: Biohazard Release at Tulane National Primate Research Center

# data[].attributes.body
A high-security Tulane lab in Louisiana accidentally released a deadly bacterium classified by the CDC as a select agent, with a mortality rate up to 50% in some regions. Despite assurances of no public risk, the release revealed significant lapses in biosafety. Monkeys outside the BSL-3 lab contracted the bacterium, yet only four soil samples were taken instead of the recommended 200. The bacterium’s potential for asymptomatic spread and weaponization intensifies concerns. This incident mirrors past controversies involving Tulane researchers, including allegations of mishandling pathogens during the Ebola outbreak, raising questions about systemic negligence in biohazard management.

# data[].attributes.body
Containment Breach

Monkeys outside the BSL-3 facility contracted the bacterium despite containment protocols designed to prevent exposure.

These animals were housed in outdoor cages, each about half the size of a football field, significantly complicating containment efforts.

Failure to Determine Cause

Lab officials could not identify how the release occurred, raising concerns about sloppy practices and insufficient safety protocols.

# data[].attributes.body
Inadequate Environmental Sampling

The lab conducted only four soil tests in the contaminated area instead of the recommended 200 samples, undermining the ability to assess the scope of the release.

Asymptomatic Spread Risk

The bacterium’s ability to rema usein asymptomatic in carriers while still spreading poses a heightened risk of undetected infections, making containment breaches even more dangerous.

# data[].attributes.body
Previous Concerns with Tulane

Tulane researchers had previously been implicated in mishandling pathogens during the Ebola outbreak in Sierra Leone, adding to concerns about systemic issues in safety and ethics.

Public and Media Response

Despite the severity of the incident, officials minimized its risks, claiming there was "no danger to the public." This downplaying, coupled with inadequate media coverage, reflected a troubling lack of accountability.

# data[].attributes.body
Biohazards

Definition

Biohazards: Biological substances that pose a threat to the health of living organisms, primarily humans. These include microorganisms, toxins, and infectious materials that can cause diseases or harm.

Common settings: Laboratories, healthcare facilities, agricultural fields, and environmental cleanup sites.

The biohazard symbol is a globally recognized emblem used to warn about the presence of biohazardous materials.

# data[].attributes.body
Types of Biohazards

Biohazards are broadly categorized into four types:

1. Infectious Agents

Definition: Pathogenic microorganisms that can cause diseases in humans or animals.

Examples:

Bacteria: Tuberculosis, anthrax.

Viruses: Ebola, HIV, Influenza.

Fungi: Aspergillus, Candida.

Prions: Creutzfeldt-Jakob disease.

Interesting Fact: Many pathogens, like the bacterium causing tuberculosis, are airborne and can spread rapidly.

2. Biological Toxins

Definition: Toxic substances produced by organisms that can cause harm without the organism itself being infectious.

Examples:

Botulinum toxin (from Clostridium botulinum).

Ricin (from castor beans).

# data[].attributes.body
biological agents or toxins that are regulated due to their potential to pose a severe threat to human, animal, or plant health.

classified based on their potential to be used as biological weapons or their ability to cause widespread harm.

# data[].attributes.body
1. Bacterial Select Agents

These are harmful bacteria that can cause severe diseases in humans, animals, or plants.

Bacillus anthracis (causes anthrax)

Yersinia pestis (causes plague)

Francisella tularensis (causes tularemia)

Clostridium botulinum (produces botulinum toxin)

2. Viral Select Agents

Viruses are obligate intracellular pathogens that can infect humans, animals, or plants, often causing devastating diseases.

Ebola virus

Marburg virus

Variola virus (causes smallpox)

Foot-and-mouth disease virus

3. Fungal Select Agents

Fungi can infect plants, humans, and animals, leading to significant agricultural losses or health issues.
- Coccidioides species (causes Valley fever)

4. Toxins

These are poisonous substances produced by living organisms, such as bacteria, plants, or fungi. They may also be synthesized artificially.

Botulinum toxin (produced by Clostridium botulinum)

Ricin (extracted from castor beans)

Abrin (found in Abrus precatorius seeds

Saxitoxin (produced by marine dinoflagellates)

5. Plant Pathogens

These agents specifically target plants, leading to significant economic losses in agriculture.

Puccinia graminis (causes wheat stem rust)

Ralstonia solanacearum (causes bacterial wilt in plants)

# data[].attributes.headline
Biological agents and toxins determined to have potential to pose threats to human and animal health 

# data[].attributes.subject
Biological agents and toxins determined to have potential to pose threats to human and animal health 

# data[].attributes.body
HHS Select Agents and Toxins

1. Abrin [6]

2. Bacillus cereus Biovar anthracis [1]

3. Botulinum neurotoxins [1][6]

4. Botulinum neurotoxin producing species of Clostridium [1]

5. Conotoxins (Short, paralytic alpha conotoxins containing the following amino acid sequence X1CCX2PACGX3X4X5X6CX7) [6]

6. Coxiella burnetii [9]

7. Crimean-Congo haemorrhagic fever virus

8. Diacetoxyscirpenol [6]

9. Eastern Equine Encephalitis virus [4][5]

10. Ebola virus [1]

11. Francisella tularensis [1]

12. Lassa fever virus

13. Lujo virus

14. Marburg virus [1]

15. Monkeypox virus [4]

16. Reconstructed replication competent forms of the 1918 pandemic influenza virus containing any portion of the coding regions of all eight gene segments (Reconstructed 1918 Influenza virus)

17. Ricin [6]

18. Rickettsia prowazekii

19. SARS-associated coronavirus (SARS-CoV) [5]

20. SARS-CoV/SARS-CoV-2 chimeric viruses resulting from any deliberate manipulation of SARS-CoV-2 to incorporate nucleic acids coding for SARS-CoV virulence factors

21. Saxitoxin [6]

South American Haemorrhagic Fever viruses:

22. Chapare

23. Guanarito

24. Junín

25. Machupo

26. Sabia

27. Staphylococcal enterotoxins (subtypes A,B,C,D,E) [6]

28. T-2 toxin [6]

29. Tetrodotoxin [6]

Tick-borne encephalitis complex (flavi) viruses:

30.Far Eastern subtype [5]

31. Siberian subtype [5]

32. Kyasanur Forest disease virus [5]

33. Omsk hemorrhagic fever virus [5]

34. Variola major virus (Smallpox virus) [1]

35. Variola minor virus (Alastrim) [1]

36. Yersinia pestis [1]

Overlap Select Agents and Toxins

37. Bacillus anthracis [1]

38. Bacillus anthracis Pasteur strain

39. Brucella abortus

40. Brucella melitensis

41. Brucella suis

42. Burkholderia mallei [1]

43. Burkholderia pseudomallei [1]

44. Hendra virus

45. Nipah virus

46. Rift Valley fever virus

47. Venezuelan equine encephalitis virus [4][5][8]

USDA Veterinary Services (VS)

Select Agents and Toxins

48. African horse sickness virus

49. African swine fever virus

50. Avian influenza virus [4]

51. Classical swine fever virus [5]

52. Foot-and-mouth disease virus [1][5]

53. Goat pox virus

54. Lumpy skin disease virus

55. Mycoplasma capricolum [4]

56. Mycoplasma mycoides [4]

57. Newcastle disease virus [3][4]

58. Peste des petits ruminants virus

59. Rinderpest virus [1]

60. Sheep pox virus

61. Swine vesicular disease virus [5]

USDA Plant Protection And Quarantine (PPQ)

Select Agents and Toxins

62. Coniothyrium glycines
(formerly Phoma glycinicola and Pyrenochaeta glycines)

63. Peronosclerospora philippinensis
(Peronosclerospora sacchari)

64. Ralstonia solanacearum [7]

65. Rathayibacter toxicus

66. Sclerophthora rayssiae [7]

67. Synchytrium endobioticum

68. Xanthomonas oryzae

# data[].attributes.body
Burkholderia pseudomallei,

Overlap select agents and toxins

The soil saprophyte

causative agent of melioidosis

a disease endemic in South East Asia and northern Australia.

classified as a Tier 1 select agent by the U.S. Federal Select Agent Program

Exposure to B. pseudomallei by either inhalation or inoculation can lead to severe disease.

international guidelines recommending handling within a class II biosafety cabinet (BSC) in a biosafety level 3 (BSL3) facility, making genetic manipulation and characterisation difficult.

Environmental determinants of this infection, apart from a close association with rainfall, are yet to be elucidated.

Melioidosis is regarded as endemic to southeast Asia and northern Australia, corresponding approximately to the tropical latitudes between 20°N and 20°S.

Mortality rates are lower in northern Australia at 10%, probably due to increased public disease awareness and better access to tertiary medical care.

“great mimicker” due to the wide variety of clinical symptoms that can be observed in patients presenting to hospitals around the globe. Therefore, early diagnosis of melioidosis is challenging for clinicians.

B. pseudomallei rapidly shifts from an environmental organism to an aggressive intracellular pathogen capable of rapidly spreading around the body.

causes a clinical spectrum ranging from pneumonia and/or cutaneous infection to disseminated disease with fulminant septicaemia.

Incident cases peak after monsoonal rains, particularly in individuals with immune dysfunction.

Documented peak rates of melioidosis occur in the NT1 and in North-eastern Thailand; however, infection is likely significantly under-diagnosed and under-reported throughout South East Asia, the Indian sub-continent, Sri Lanka, China and Papua New Guinea.

There are increasing numbers of reports of sporadic cases from Central and South America, Africa, the Middle East, the Caribbean, the Pacific (eg New Caledonia) and Indian Oceans (eg Mauritius).

The estimated annual global disease burden of melioidosis is approximately 165,000 cases, including 89,000 deaths.

Human melioidosis occurs in people of all ages, although peak disease incidence occurs in adults aged between 40 and 60 years.

Melioidosis incidence and disease severity is determined by host, environmental and strain-specific virulence factors.

Retrospective reviews of Australian and Thai cohorts have identified many host risk factors for melioidosis including diabetes mellitus, heavy alcohol consumption (including binge drinking) and chronic kidney and lung disease.

Individuals with increased exposure to soil and water in endemic areas are at highest risk of infection, including Aboriginal and Torres Strait Islander peoples, agricultural workers, construction workers and ecotourists. Strong correlations exist between melioidosis cases and mean monthly rainfalls (Figure 1), with epidemiologic studies demonstrating that 81% of Australian cases occur during the wet season.

B. pseudomallei vaccines remain in pre-clinical investigation as of 2021.The protection against chronic and persistent forms of melioidosis disease is a challenge for further vaccine development

# data[].attributes.body
cases elsewhere in the world are rare and almost always attributable to travel to regions of endemicity.

The genome sequences of several B. pseudomallei strains have been determined, and efforts are being initiated to take advantage of this information to learn more about the biology and pathogenesis of these bacteria.

Prior to its designation in the United States as a category B select agent, there had been steady progress toward the development and use of genetic methods for manipulating B. pseudomallei .

efforts are now severely hampered because of strict select-agent guidelines which restrict the use of antibiotic resistance selection markers to those that do not conflict with application of the respective antibiotics in human and veterinary medicine as well as agriculture.

Bioterrorism Potential:

A concern due to its ability to remain undetected in environmental reservoirs, resistance to many antibiotics, and the challenges in early diagnosis.

It has been studied as a potential biological weapon because it can cause widespread illness if aerosolized.

Laboratory Hazards:

Laboratory personnel working with this bacterium are at risk of exposure through accidental aerosolization or mishandling of specimens.

Strict biosafety protocols are required when handling it.

Treatment

prolonged antibiotic regimens:

1. Initial intravenous antibiotics (e.g., ceftazidime or meropenem) for 2-8 weeks.

2. Oral antibiotics (e.g., trimethoprim-sulfamethoxazole) for 3-6 months to prevent relapse.

Surveillance and Response:

The Centers for Disease Control and Prevention (CDC) actively monitors melioidosis cases

supports public health investigations, and provides resources for emergency response in suspected bioterrorism events.

# data[].attributes.body
1.Bacterial Toxins

Produced by bacteria, these toxins can affect various systems in the body.

Exotoxins (released by bacteria):
Botulinum toxin (by Clostridium botulinum): Causes botulism, a severe paralytic disease.

Cholera toxin (by Vibrio cholerae): Disrupts ion transport in intestines, causing severe diarrhea.

Tetanospasmin (by Clostridium tetani): Causes tetanus, leading to muscle spasms.

Endotoxins (part of bacterial cell walls, released upon cell death):
- lipopolysaccharides (LPS) from Escherichia coli or Salmonella: Can cause septic shock.

# data[].attributes.body
2. Plant Toxins

Derived from plants, these can have toxic effects on humans and animals.

Ricin (from castor beans): A potent toxin that inhibits protein synthesis.

Coniine (from hemlock): A neurotoxin causing paralysis.

Cyanogenic glycosides (in cassava or stone fruits): Release cyanide when metabolized.

3. Animal Toxins

Produced by animals as a defense or predation mechanism.

Venoms:

Snake venom (e.g., cobras, vipers): Contains neurotoxins (e.g., alpha-bungarotoxin) or hemotoxins that affect the nervous system or blood.

Scorpion venom: Neurotoxic effects causing pain and systemic symptoms.

Toxins in secretions:

Tetrodotoxin (in pufferfish): Blocks sodium channels, leading to paralysis.

Bufotoxin (from toads): Affects the heart and nervous system.

4. Fungal Toxins (Mycotoxins)

Produced by fungi, these toxins can contaminate food or cause infections.

Aflatoxins (by Aspergillus species): Contaminate grains and nuts, leading to liver damage.

Ergot alkaloids (by Claviceps purpurea): Cause ergotism, with symptoms like convulsions or gangrene.

Ochratoxin A (by Penicillium and Aspergillus): Affects kidneys and is carcinogenic.

5. Marine Toxins

Produced by marine organisms, often through algae, and can accumulate in seafood.

Saxitoxin: Causes paralytic shellfish poisoning.

Ciguatoxin: Found in reef fish, causing ciguatera fish poisoning.

Domoic acid: Causes amnesic shellfish poisoning.

6. Synthetic or Chemical Toxins

Artificially produced toxins often mimic biological toxins.

Organophosphates: Used in pesticides and nerve agents (e.g., sarin).

Dioxins: Byproducts of industrial processes, causing cancer and immune dysfunction.

7. Environmental Toxins

Substances from natural or anthropogenic sources.

Lead: A heavy metal causing neurological and developmental damage.

Mercury: A neurotoxin found in contaminated fish or industrial waste.

# data[].attributes.body
3. Environmental Biohazards

Definition: Natural or man-made sources of biological contamination in the environment.

Examples:

Contaminated water carrying cholera bacteria.

Soil harboring anthrax spores.

Biowaste from hospitals.

4. Biological Weapons

Definition: Biological agents intentionally used in warfare or terrorism to harm populations.

Examples:

Anthrax spores (used in 2001 U.S. attacks).

Smallpox virus (historically weaponized).

Interesting Fact: Biological weapons are restricted under the Biological Weapons Convention (BWC).

# data[].attributes.body
A person dealing with this level of biohazards must wear a lab coat, gown, or uniform to prevent contamination of personal clothing

It is also recommended to wear safety glasses in the laboratory or when dealing with experiments/procedures that have the potential to create splashes of biohazards

Gloves must be worn to protect our hands from exposure

Should change if it is contaminated with the biohazards or when there is damage to the gloves

Wash hands before leaving the laboratory

# data[].attributes.body
Lab coats should be worn when working with hazardous materials but should remain in the laboratory.

disposable or reusable

Removed before leaving the safety level zone

Safety glasses are recommended while working with the materials in the laboratory.

Eye and face protection like goggles, masks or face shields should be used if dealing with microorganisms / infectious materials outside the Biological Safety Cabinets.

Not required if one is transporting closed containers of biohazards between the BSC and storage

Gloves:

Nitrile gloves are usually preferred when dealing with materials in this level

Must be changed when contaminated or when there is damage

Must be removed, then wash hands after working with biohazards before leaving the laboratory

Must not be washed and reused, immediately discard it in waste bins

# data[].attributes.body
1. BSL -1 ( low risk)

Collection:

Basic PPE ( lab coat, gloves & safety glasses)

Collect in non-contaminated containers

Treatment: autoclaving (121°C for 15-20 minutes)

Disposal:

Once sterilized, materials can be disposed of in regular waste streams ( trash bins)

For contaminated materials, disposal in regular biohazard waste containers is appropriate after autoclaving

# data[].attributes.body
2. BSL -2 (moderate risk)

Collection:

Basic PPE

Collect in biohazard-labeled containers

Treatment:

autoclaving (121°C for 15-20 minutes)

chemical disinfection (for liquid waste - bleach/hydrogen peroxide)

Disposal:

After autoclaving and cooling, dispose of the waste in biohazard waste containers

For soil and water, dispose of waste through approved biohazard waste disposal methods ( incineration or secure landfills)

# data[].attributes.body
3. BSL - 3 ( high risk)

Collection:

enhance PPE - Full lab attire (scrubs, gloves, goggles), powered air-purifying respirators (PAPR), and protective suits should be worn when handling contaminated soil or water.

Sealed, biohazard-labeled containers must be used for collection

Treatment:

autoclaving at higher temperatures and longer cycles to ensure complete sterilization (typically 121°C, 30 minutes or more)

Disinfection (use disinfectant eg. chlorine/formaldehyde)

Disposal:

After sterilization, waste is disposed of through biohazard waste disposal system ( secure landfills, incineration)

Double-bagging / sealing waste in special containers to ensure no contamination during disposal is mandatory

# data[].attributes.body
Lab workers are not allowed to wear any personal clothes, shoes, or jewelry

Must change into facility-captured scrubs and shoes

Either a solid-front gowning or Tyvek suit is required

A powered, air-purifying respirator (PAPR) must be worn at all times within the high containment area

Double gloves is worn and used in the HCA; nitrile gloves are preferred as it provide better protection

# data[].attributes.body
Wear a full-body, air-supplied, positive-pressure suit

2 pairs of gloves, scrubs and shoes are also worn inside the suit

Why positive air pressure?

If there is damage to the suit, air will flow out instead of flowing inside which reduces the risk of contamination

Also include HEPA filters to trap bacteria, fungi, and viruses larger than 0.3 microns, and provide cleaner air

# data[].attributes.body
4. BSL -4 (very high risk)

Collection:

Full-body, positive-pressure suits (air-supplied suits), double-gloved, and respiratory protection (PAPR) are mandatory

All collection should occur inside high-containment areas with negative pressure to prevent exposure to the outside environment.

Treatment:

Autoclaving and incineration: Waste, including soil and water, must be thoroughly sterilized, typically through high-pressure autoclaving, followed by incineration for ultimate destruction.

Chemical Disinfection: Strong disinfectants (e.g., formaldehyde, chlorine dioxide) may be used for further decontamination, especially for liquid waste.

UV Light and Chemical Sterilization: These may be used in some cases to further ensure that all pathogens are destroyed

Disposal:

Waste must be contained in biohazardous waste containers designed for maximum security.

After treatment, the waste must be disposed of through incineration or another method that guarantees complete pathogen destruction.

Any transport of waste must involve sealed, double-locked containers, and the waste should be sent to high-security disposal facilities.

# data[].attributes.body
Time is of the essence, immediately wash the wound and seek assistance as some biohazard/pathogens have short incubation time

For percutaneous injuries

Wash the site immediately with soap and water.

Do not use harsh detergents or abrasive scrubbing on wounds. This can just worsen the injury or introduce new hazards into the body

Do not suck the site with your mouth as it risks contaminating the mouth and digestive tract

For mucous membrane exposure

Flush the affected areas immediately and thoroughly with water.

Rinse the eyes at the eyewash station if it's available

Do not use harsh detergents or abrasive scrubbing on wounds. This can just worsen the injury or introduce new hazards into the body

After Performing First Aid

Report the incident immediately to relevant supervisors

Do not keep it as a secret or wait for a few days before reporting

# data[].attributes.body
Used to identify the protective measures needed in a laboratory setting to protect workers, the environment and the public [1]

Different levels are used to handle various types of risks and are defined in Biosafety in Biomedical Laboratories (BMBL)

The levels consist of BSL-1, BSL-2, BSL-3 and BSL-4

The biosafety level designation in the BMBL outlines specific practices and safety and facility requirements

# data[].attributes.body
Used to study infectious agents or toxins not known to consistently cause disease in a healthy adult

Must follow basic safety procedures Standard Microbiological Practices

No special equipment or design features required

Standard engineering controls include easily cleaned surfaces that can withstand basic chemicals used in the lab [1]

# data[].attributes.body
Used to study moderate-risk infectious agents or toxins that pose a risk if accidentally inhaled, swallowed or exposed to the skin.

Design requirements include hand washing sinks, eye washing stations in case of accidents and doors that close automatically and lock

Must have access to equipment that can decontaminate lab waste, like an incinerator, autoclave, and/or another method depending on biological risk assessment AND Class II biosafety cabinet

Contaminated sharps are handled with extreme caution (since we are dealing with Hep B and HIV)

The use of disposable syringe-needle units and appropriate puncture-resistant sharps containers is mandatory [2], also to prevent percutaneous injury, ingestion and mucous membrane exposures in addition to the SMP in BSL-1

Direct handling of broken glassware is prohibited

Decontamination of all sharps prior to disposal is standard practice

The labs written biosafety manual details any needed immunizations (hep B vaccine or TB skin testing) and whether serum banking is required for at risk lab personnel

Access to the lab is more controlled than BSL-1 facilities

Immunocompromised, immunosuppressed and other persons with increased risk of infection may be denied admittance

# data[].attributes.headline
3. BSL-3: High risk with potential for aerosol transmission

# data[].attributes.subject
3. BSL-3: High risk with potential for aerosol transmission

# data[].attributes.body
Used to study infectious agents or toxins that may transmit through the air and cause potentially lethal infection through inhalation exposure

The pathogenicity and communicability of these agents dictates the next level of protective procedures and barrier [2]

Add all of BSL-2 practices equipment with more stringent access control and decontamination of all wastes, including lab clothing before laundering, within the lab facility

Must perform all experiments in a biosafety cabinet that uses carefully controlled air flow OR sealed enclosures to prevent infection

Must be designed to be easily decontaminated

Must use controlled or directional airflow to ensure air flows from non-laboratory areas (hallway) into lab areas (with no recirculation) as additional safety measures

Baseline serum samples are collected from all labs and other at-risk personnel as appropriate [2]

More protective primary barriers are used in BSL-3 lab, including solid-front wraparound gowns, scrub suits or coveralls made of materials such as Tyvek® and respirators as necessary

Must incorporate self-closing double-door access separated from general building corridors

# data[].attributes.body
Used to study infectious agents or toxins that pose a high risk of aerosol-transmitted laboratory infections and life-threatening diseases for which no vaccine or therapy is available

The lab incorporates all BSL-3 features and occupies safe, isolated zones within a larger building or may be housed in a separate, dedicated building

Accessing the BSL-4 lab is carefully controlled and requires significant training

Two types of BSL-4 labs:

1. Cabinet laboratory - all work is done in a Class III Biosafety Cabinet with very carefully designed procedures to contain any potential contamination.

The lab space is designed to also prevent contamination of other spaces

2. Suit laboratory - lab personnel are required to wear full-body, air-supplied suits which are the most sophisticated type of PPE.

All personnel shower before exiting the lab and go through a series of procedures designed to fully decontaminate them before leaving.

# data[].attributes.body
1. Risk Group 1 (RG1): Minimal Risk

Characteristics:

These are agents that are unlikely to cause disease in healthy humans, animals, or plants.

They are often used in educational or research settings for training and basic experiments.

Examples:

Non-pathogenic strains of E. coli (e.g., E. coli K-12).

Bacillus subtilis, a common soil bacterium.

Containment Requirements:

Standard microbiological practices (e.g., proper hand hygiene and surface cleaning).

No special containment or protective equipment is required.

# data[].attributes.body
2. Risk Group 2 (RG2): Moderate Risk

Characteristics:

These agents can cause diseases that are typically mild to moderate in severity and are not easily transmitted to the community.

Effective treatments (e.g., antibiotics, antivirals) or preventive measures (e.g., vaccines) are usually available.

Examples:

Salmonella spp.: Causes foodborne illnesses.

Hepatitis B virus: Spread through contact with infected blood or body fluids.

Staphylococcus aureus: Can cause skin infections and more serious systemic infections.

Containment Requirements:

Biosafety Level 2 (BSL-2) protocols, including restricted access, use of personal protective equipment (PPE), and biological safety cabinets for certain procedures.

# data[].attributes.body
3. Risk Group 3 (RG3): High Risk

Characteristics:

These agents are associated with serious or potentially lethal diseases.

They may spread to individuals through inhalation, contact, or ingestion, and some may pose a community-level risk.

Effective medical countermeasures may exist but are not always accessible or foolproof.

Examples:

Mycobacterium tuberculosis: Causes tuberculosis, primarily spread through respiratory droplets.

Bacillus anthracis: Causes anthrax; inhalation forms can be fatal if untreated.

Yersinia pestis: Causes plague, including its deadly pneumonic form.

Containment Requirements:

Biosafety Level 3 (BSL-3) laboratories with specialized ventilation systems (e.g., negative air pressure).

Strict protocols for access, PPE use (e.g., respirators), and waste decontamination.

# data[].attributes.body
4. Risk Group 4 (RG4): Extreme Risk

Characteristics:

These agents are highly infectious and often fatal, with no known effective treatments or vaccines.

They pose significant risk to both laboratory workers and the surrounding community due to their ability to spread rapidly.

Examples:

Ebola virus: Causes hemorrhagic fever with high mortality rates.

Marburg virus: Similar to Ebola, causing severe hemorrhagic fever.

Variola virus: Causes smallpox, eradicated globally but remains a high-risk pathogen in bioterrorism contexts.

Containment Requirements:

Biosafety Level 4 (BSL-4) facilities, which are the highest level of containment.

Workers must use full-body, air-supplied suits and undergo strict decontamination procedures upon exiting.

The facility must have independent air systems, advanced filtration, and secure waste management systems.

# data[].attributes.headline
Roles and responsibilities in OSHA Safety Program

# data[].attributes.subject
Roles and responsibilities in OSHA Safety Program

# data[].attributes.body
Good communication and interaction among the functional areas is important to ensure that biohazards are properly identified and reviewed by a group with appropriate expertise and that the necessary safeguards are in place to protect the personnel working with the hazards.

The regulations and guidance summarized provide a framework for institutional responsibilities for oversight of research involving biohazards and for definifn responsibilities of the various group.

Institution are defined as any public or private entity participating in research using biological hazards.

Institutions conducting research with biologic hazards must ensure safe workplaces and compliance with regulatory standards.

This includes creating internal programs to manage risks, comply with regulations, and educate personnel.

Institutions are responsible for setting policies, allocating resources, and overseeing safety programs through designated committees or roles.

Leadership plays a key role in understanding safety issues, supporting policies, and fostering a culture of compliance and collaboration.

# data[].attributes.headline
Environmental health and safety and occupational health. 

# data[].attributes.subject
Environmental health and safety and occupational health. 

# data[].attributes.body
the main concern of environmental health and safety programs for the use of biohazards is to prevent release of organisms or toxins outside of the controlled research environment and to prevent infection of personnel, the public, and the environment.

provides technical services that assist the institution in carrying out its regulatory and legal responsibilities associated with health and safety; this program involves people who have expertise in chemical safety, biologic safety, physical safety, industrial hygiene, health physics and radiation safety, engineering, environmental health, fire safety, and toxicology.

provide programs to collect, transport, and dispose of hazardous waste; manage responses to emergencies; monitor regulatory compliance; and provide training support and technical assistance.

# data[].attributes.body
The Institutional Biosafety Committee (IBC) is a central authority within organizations that ensures research involving biological hazards complies with safety standards, protects personnel, and mitigates risks. Its comprehensive role involves designing and overseeing policies and procedures that address biosafety and biosecurity concerns.

Composed of members with diverse technical and scientific expertise to address all aspects of biosafety and biosecurity relevant to an institution's activities.

Biosafety and Biosecurity: Includes experienced biosafety officers to guide technical safety practices.

Microbiology: Specialists in bacteriology, virology, parasitology, and related fields to assess pathogen-related risks.

Emerging Technologies: Experts in areas like gene editing and synthetic biology assess the implications of cutting-edge research.

Veterinary Practices and Zoonoses: Knowledgeable personnel ensure proper handling of animals and reduce zoonotic disease risks.

Members may include professionals in legal compliance, facility operations, bioethics, and epidemiology. External experts may also be consulted for specific, high-consequence research projects to complement the IBC’s knowledge.

# data[].attributes.body
Institutional Biosafety Committee (IBC) is mandated by the NIH Guidelines to review, approve, and oversee projects involving recombinant or synthetic nucleic acid molecules conducted at or sponsored by the institution.

For projects using animal subjects, the IBC membership must include someone with expertise in animal research.

Although the IBC is not required to oversee other types of biologic hazards research, this group or a similar safety oversight committee is usually tasked with the review and approval of work using nonrecombinant biohazards as well as select agents.

IBC is responsible for reviewing projects that involve, but are not limited to, recombinant DNA, RNAi, pathogens, human materials and other potentially infectious material, as well as transgenic animals.

provides recommendations to the intramural community in matters pertaining to the control of biohazards associated with the use of microbiological agents and their vectors.

IBC (or other safety committee) provides the primary mechanism representing institutional oversight of biologic hazards research

# data[].attributes.body
Need to have a biosafety officer

defined in the NIH Guidelines is the role of the biosafety officer for institutions using large-scale production of recombinant or synthetic nucleic acids and the use of these materials at biosafety level 3 or 4.

responsible for laboratory inspections, reporting of noncompliance, reporting of research related accidents or illnesses, developing emergency plans, and providing advice on laboratory security.

A specific person must be designated as an institution's biosafety officer when select research is conducted

institutions may elect to assign these responsibilities collectively to safety personnel and the environmental health and safety departments.

# data[].attributes.body
A principal investigator or laboratory director is the person who oversees research projects using biohazards and the laboratory personnel responsible for the work.

should work closely with the IBC and other oversight bodies and personnel at the institution to ensure compliance with regulations and policies for the use of hazards and research.

ensure that work has been evaluated and approved before conduct, report significant problems or violations of regulations and policies, report new information and updates regarding the hazard and its use, and ensure that personnel are trained in appropriate techniques.

# data[].attributes.body
The Centers for Disease Control and Prevention (CDC) plays a vital role in managing biohazards by setting national biosafety standards, offering training, and providing guidance for handling infectious agents. Key functions include:

1. Establishing Biosafety Guidelines: The CDC publishes the Biosafety in Microbiological and Biomedical Laboratories (BMBL) manual, a core resource for safe laboratory practices.

2. Monitoring Pathogens: It oversees high-containment facilities handling dangerous pathogens.

3. Emergency Response: The CDC supports response to biohazard emergencies, like outbreaks or bioterrorism threats.

4. Training and Oversight: It offers resources and inspections to ensure compliance with biosafety standards.,

# data[].attributes.body
Environmental Protection Agency (EPA) contributes to addressing biohazardous infectious diseases, primarily through its role in environmental health and regulation. Its key responsibilities include:

1. Regulation of Disinfectants: The EPA ensures that disinfectants used to control biohazards meet efficacy and safety standards, especially for pathogens like viruses and bacteria. It approves and regulates antimicrobial products under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA).

2. Environmental Contamination Response: The EPA manages the containment, cleanup, and disposal of biohazardous materials released into the environment. For example, during outbreaks, it oversees waste disposal and sanitation strategies to prevent the spread of infectious agents.

3. Collaborative Efforts: The EPA works with other federal agencies, such as the CDC and OSHA, to establish guidelines for managing infectious waste, particularly in cases of emerging or re-emerging infectious diseases.

4. Safe Water and Air Standards: It regulates water and air quality to prevent the spread of infectious diseases caused by contaminated sources. For instance, the EPA addresses pathogens like Legionella in water systems.

5. Pandemic and Bioterrorism Preparedness: The EPA participates in federal emergency planning for bioterrorism and pandemics, focusing on environmental decontamination and waste management.

# data[].attributes.body
Infectious waste management by EPA

The Environmental Protection Agency (EPA) oversees the management of infectious waste to minimize environmental and public health risks. Infectious waste includes items contaminated with blood, bodily fluids, or pathogens capable of causing infections. Key aspects of EPA's infectious waste management include:

1. Definition and Classification: Infectious waste includes sharps (e.g., needles), lab waste, contaminated PPE, and biological specimens.

2. Treatment Standards: It mandates proper sterilization, incineration, or alternative treatments like autoclaving to neutralize pathogens.

3. Storage and Transportation: Infectious waste must be securely stored in leak-proof, labeled containers and transported by licensed handlers.

4. Disposal: Treated waste can often be disposed of in municipal landfills or through specialized hazardous waste facilities.

While the CDC leads public health efforts for infectious diseases, the EPA plays a complementary role by focusing on environmental safety and mitigating risks associated with biohazards in natural and built environments.

# data[].attributes.body
Discussion

# data[].attributes.body
Biosafety Level 1 (BSL-1)

Examples: Non-pathogenic E. coli, Bacillus subtilis

Collection:

Work on open benchtops.

Use basic PPE (e.g., gloves, lab coats).

Collect samples in standard containers.

Treatment:

Autoclave all materials before disposal.

Disinfect work surfaces with 10% bleach or ethanol after handling.

Disposal:

Place decontaminated waste in standard municipal trash if regulations permit.

Biosafety Level 2 (BSL-2)

Examples: Salmonella spp., Staphylococcus aureus

Collection:

Conduct work in a Class II biosafety cabinet (BSC) when aerosols or splashes are likely.

Use sealed, labeled containers for transport.

Treatment:

Autoclave solid waste.

Chemically disinfect liquid waste (e.g., sodium hypochlorite, phenolic compounds).

Disposal:

Treated waste should be handed to authorized biohazard waste disposal facilities.

Biosafety Level 3 (BSL-3)

Examples: Mycobacterium tuberculosis, Bacillus anthracis

Collection:

Work exclusively within a Class II or III BSC.

Double containment: use sealed primary and secondary containers.

Decontaminate samples before transport (e.g., wipe with 70% ethanol).

Treatment:

Autoclave or incinerate waste within the containment zone.

Chemically disinfect liquid waste before removal.

Disposal:

Transport decontaminated waste to licensed high-risk disposal facilities.

Document disposal records thoroughly.

Biosafety Level 4 (BSL-4)

Examples: Ebola virus, Marburg virus

Collection:

Work in a Class III BSC or wear a positive-pressure suit.

Triple containment for samples (primary container, sealed secondary container, and rigid outer packaging).

Treatment:

Autoclave or incinerate all waste on-site.

Use advanced disinfection techniques (e.g., peracetic acid or vaporized hydrogen peroxide).

Disposal:

Treated waste is incinerated or rendered inert before off-site transport.

Ensure compliance with international hazardous waste transport regulations.

Key Notes

Containment Levels: Increase progressively with biohazard levels. Always adhere to the facility's infrastructure requirements.

Personnel Training: Personnel must be adequately trained and authorized for BSL-3 and BSL-4 work.

Regulations: Follow country-specific guidelines such as NIH, OSHA, CDC, WHO, or local authorities.